AMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptor

G A Donzella, Dominique Schols(Rega Institute for Medical Research), Steven Lin(Rockefeller University), José A. Esté(Rega Institute for Medical Research), Kirsten Nagashima(Progenics Pharmaceuticals (United States)), Paul J. Maddon(Progenics Pharmaceuticals (United States)), Graham P. Allaway(Progenics Pharmaceuticals (United States)), Thomas P. Sakmar(Howard Hughes Medical Institute), Geoffrey Henson, Erik De Clercq(Rega Institute for Medical Research), John P. Moore(Aaron Diamond AIDS Research Center)
Nature Medicine
January 1, 1998
Cited by 763

Abstract


Related Papers

No related papers found

Powered by citation graph analysis